HER-2 amplification and topoisomerase II alpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil
収録刊行物
-
- Clin Cancer Res
-
Clin Cancer Res 8 1107-1116, 2002
- Tweet
詳細情報
-
- CRID
- 1570854175416485760
-
- NII論文ID
- 10018769092
-
- データソース種別
-
- CiNii Articles